Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study

SIMPLE SUMMARY: We aimed to compare the prognosis of patients with advanced hepatocellular carcinoma treated with the first-line atezolizumab plus bevacizumab (AB) combination chemotherapy and the less popular locoregional treatment mainly used in East Asia, hepatic artery infusion chemotherapy (HAI...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji Hoon, Nam, Hee-Chul, Kim, Chang-Wook, Cho, Hee Sun, Yoo, Jae-Sung, Han, Ji Won, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew, Yang, Hyun, Bae, Si Hyun, Kim, Suho, Oh, Jung Suk, Chun, Ho Jong, Jeon, Chang Ho, Ahn, Jaegyoon, Sung, Pil Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487133/
https://www.ncbi.nlm.nih.gov/pubmed/37686509
http://dx.doi.org/10.3390/cancers15174233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487133/
https://www.ncbi.nlm.nih.gov/pubmed/37686509
http://dx.doi.org/10.3390/cancers15174233

Ejemplares similares